The future of drugs is all in the family
In a first-ever comprehensive study of the species origins of nature-derived drugs, it is shown that drug-producing species are concentrated and clustered in a limited number of families, refuting the conventional view that as every nature species produces biologically active molecules, one can find drugs from almost any major block of species groups if one looks for them hard enough.
Whether you have a mild headache or you are running a fever, there is a high chance that the drug that is used to treat you comes from nature. Today, about half of the drugs on the market were discovered by screening collections of small molecules made by bacteria, fungi, snails, leeches and other such species.
In Singapore, the top selling drugs for treating common ailments that are derived from nature include No. 12 Aspirin (for pain, fever and inflammation), No. 2 Amoxil (antibiotic), No. 7 Procodin (for cough), No. 8 Beserol (muscle relaxant) and No. 3 Ventolin (for asthma and chronic obstructive pulmonary disease).
Worldwide, eight of the top 20 selling drugs available today are derived from nature, some of which include No. 2 Lipitor and No. 9 Crestor (both for treating cholesterol), No. 4 Advair Diskus (for asthma), No. 15 Lantus (for diabetes), and No. 18 Diovan (for hypertension).
Another six of the top 20 selling drugs in the world are mimics of natural products. No. 6 Abilify (for psychosis and depression), No. 7 Singulair (for asthma), No. 10 Cymbalta (for depression and anxiety disorders) are some of the examples.
Although the pharmaceutical industry has made serious efforts to get away from relying on the natural world by attempting to create rationally designed drugs using synthetic compounds, nature-derived drugs still constitute a substantial percentage (26%) of recently approved drugs.
Nature-derived drugs not in every species
The conventional view about nature-derived drugs is that as every nature species produces biologically active molecules, one can find drugs from almost any major block of species groups if one looks and searches for them hard enough.
This view has been proven wrong in a first-ever comprehensive study of the species origins of nature-derive drugs conducted by researchers from the National University of Singapore (NUS) and Tsinghua University. Published in Proceedings of the National Academy of Sciences of the United States of America in July 2011, the research showed that drug producing species are concentrated and clustered in a limited number of families.
Data analysed by the research team showed that out of 886 nature-derived drugs discovered in the last 50 years (1961 to 2010), 88% or 783 were from previously known drug producing families. A further 41 were from near neighbours of known productive families. Only 62 came from 'dark horses' that were completely outside of the known clusters.
Lead researcher Professor Chen Yu Zong from the Department of Pharmacy at NUS, said, "In each kingdom of life, the drug-producing families are strongly clustered. Only a limited number of molecular scaffolds are privileged drug-like structure made by specific metabolic genes in certain species families. Some families with lots of bioactive compounds have never produced a drug because their metabolic genes are not capable of producing privileged drug-like structures, even though they can produce bioactive structures. "
Focus on family members
The findings from this research can now point us to the direction on where to concentrate on the search for new drugs, and that is from pre-existing drug-productive families.
In explaining this rationale, Prof Chen said, "We have identified and highlighted a number of families that have not produced an approved drug but are likely in the drug-producing clusters and potentially produce future approved drugs. Just like by knowing the clustered distribution patterns of oil fields, one knows where to place their bets on the next oil field based on existing findings. For instance, if one finds the first oil-producing well somewhere in the South China seas, by knowing that oil fields tend to be clustered, there is a higher chance in finding the next oil fields by a search of the surrounding areas."
By focusing on pre-existing drug-productive families, resources can be concentrated on manipulating and expanding the families for producing new, as well as existing drugs. In addition, these pre-existing drug-productive families can be studied on why they produce privileged drug-like structures, and the knowledge can be used for designing new and novel drugs.
The potential impact of the research, concludes Prof Chen, is "to promote bioprospecting efforts on those species and species families that are likely to produce new drugs, thus enabling the increase of new drug productivity."
Provided by National University of Singapore
- New 'matrix of harm' for drugs of abuse Mar 23, 2007 | not rated yet | 0
- Impeding U.S. generic drug use criticized Apr 19, 2006 | not rated yet | 0
- New Way To Predict Drug Side Effects Nov 11, 2009 | not rated yet | 0
- Scientists solve mystery of polyketide drug formation Apr 01, 2008 | not rated yet | 0
- Toward an effective treatment for a major hereditary disease Oct 13, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
How can there be a term called "intestinal metaplasia" of stomach
13 hours ago Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
- More from Physics Forums - Medical Sciences
More news stories
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Medications 2 hours ago | 5 / 5 (1) | 0
Transparent information on the evidence supporting global recommendations on paediatric medicines should be easily accessible in order to help policy makers decides on what drugs to include in their national drug lists, according ...
Medications 3 hours ago | not rated yet | 0
Regardless of pain, social class or age, a woman is more likely to be prescribed pain-relieving drugs. A study published in Gaceta Sanitaria (Spanish health scientific journal) affirms that this phenomenon is inf ...
Medications 11 hours ago | not rated yet | 0
A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, ...
Medications May 20, 2013 | 5 / 5 (1) | 0
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
9 hours ago | 4 / 5 (4) | 0 |
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
7 hours ago | 4.8 / 5 (6) | 0 |
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
3 hours ago | 5 / 5 (3) | 0 |
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
4 hours ago | not rated yet | 0 |
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
9 hours ago | 4.8 / 5 (4) | 0 |
By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...
3 hours ago | not rated yet | 0